Capitale Di Prestito Cambiamento Data
argenx SE USD 36M 432K 2026-06
AstraZeneca USD 28.8B 2.79B 2026-09
Biogen USD 7.29B 1.7M 2026-09
Genmab DKK 4.96B 28M 2026-06
Gilead Sciences USD 23.82B 17M 2026-09
GlaxoSmithKline GBP 21.7B 7.75B 2026-09
GRIFOLS EUR 8.69B 1.52B 2026-09
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Incyte USD 28.42M 994K 2026-06
Merck EUR 10.34B 866M 2026-09
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 38.38B 893M 2026-09
Roche Holding CHF 25.22B 2.21B 2026-06
Sanofi EUR 16.28B 1.63B 2026-09
UCB EUR 2.18B 634M 2025-12
Vertex Pharmaceuticals USD 3.5B 3.39B 2026-09